title: Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control.
abstract: Cystic fibrosis-related diabetes (CFRD) is a frequent complication of cystic fibrosis. We report the significant improvement of diabetes control and quality of life in a CFRD patient using the sensor-augmented insulin pump. The system gives the patient the highest degree of flexibility, which is required in CFRD since food intake and activity levels vary widely from day to day, depending on the rapid changes of health status.
authors.affiliation: Department of Metabolic Diseases, Medical College, Jagiellonian University, Krakow, Poland. tomasz_klupa@yahoo.com
authors.forename: Tomasz
authors.initials: T
authors.lastname: Klupa
authors.forename: Maciej
authors.initials: M
authors.lastname: Małecki
authors.forename: Barbara
authors.initials: B
authors.lastname: Katra
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Cyganek
authors.forename: Jan
authors.initials: J
authors.lastname: Skupień
authors.forename: Ewa
authors.initials: E
authors.lastname: Kostyk
authors.forename: Jacek
authors.initials: J
authors.lastname: Pietrzyk
authors.forename: Jacek
authors.initials: J
authors.lastname: Sieradzki
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000097:blood / Q000150:complications*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin